Isolation of bacterial extracellular vesicles from raw samples using a portable microstructured electrochemical device

Bacterial extracellular vesicles (EVs) are nanosized vesicles released by both Gram-negative and Gram-positive bacteria, playing critical roles in microbial communication, host-pathogen interactions, and immune modulation. Despite their significance in research and clinical applications, conventional isolation methods, such as ultracentrifugation (UC), are often slow, labor-intensive, and susceptible to contamination. In this study, we evaluated a novel portable microstructured electrochemical device (PMED) designed for rapid and selective bacterial EV isolation directly from biological samples. Using immunoaffinity-based capture and voltage-triggered release, the device-isolated EVs from Gram-negative Escherichia coli (E. coli), Gram-positive Lactobacillus fermentum (Lb. fermentum) culture supernatants and from urine samples spiked with E. coli , showing superior purity compared to UC. Characterization through nanoparticle tracking analysis (NTA), dynamic light scattering (DLS), and Western blot confirms enhanced selectivity and reduced contaminants. Functional assays demonstrated that device-isolated Lb. fermentum EVs selectively activated Toll-like receptor 4 (TLR4) without triggering TLR2, unlike UC-isolated EVs, suggesting a more refined immunomodulatory effect. These findings highlight the device's translational potential for EV-based diagnostics, particularly for noninvasive urinary tract infection detection, and its broader applications in studying bacterial communication and immune regulation.

Authors

Institutions

Publication Details

Journal
Drug Delivery and Translational Research
Published
2025-08-26
DOI
https://doi.org/10.1007/s13346-025-01954-1
Citations
2
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
2.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Isolation of bacterial extracellular vesicles from raw samples using a portable microstructured electrochemical device

Renato Zenobi, Naresh Kumar, Sibilla Sander, Vadim Krivitsky et al.
2 citations
Drug Delivery and Translational Research
Bacterial Infections and Vaccines
2.37
article

Isolation of bacterial extracellular vesicles from raw samples using a portable microstructured electrochemical device

Renato Zenobi, Naresh Kumar, Sibilla Sander, Vadim Krivitsky, Finn Brigger, Jörn Dengjel, Jean‐Christophe Leroux, Siiri Bienz, Nicole Zoratto, Valeria Mantella, Steffen Honrath, Edouard Baulier, Marie Ramus
article en
2 citations

Abstract

Bacterial extracellular vesicles (EVs) are nanosized vesicles released by both Gram-negative and Gram-positive bacteria, playing critical roles in microbial communication, host-pathogen interactions, and immune modulation. Despite their significance in research and clinical applications, conventional isolation methods, such as ultracentrifugation (UC), are often slow, labor-intensive, and susceptible to contamination. In this study, we evaluated a novel portable microstructured electrochemical device (PMED) designed for rapid and selective bacterial EV isolation directly from biological samples. Using immunoaffinity-based capture and voltage-triggered release, the device-isolated EVs from Gram-negative Escherichia coli (E. coli), Gram-positive Lactobacillus fermentum (Lb. fermentum) culture supernatants and from urine samples spiked with E. coli , showing superior purity compared to UC. Characterization through nanoparticle tracking analysis (NTA), dynamic light scattering (DLS), and Western blot confirms enhanced selectivity and reduced contaminants. Functional assays demonstrated that device-isolated Lb. fermentum EVs selectively activated Toll-like receptor 4 (TLR4) without triggering TLR2, unlike UC-isolated EVs, suggesting a more refined immunomodulatory effect. These findings highlight the device's translational potential for EV-based diagnostics, particularly for noninvasive urinary tract infection detection, and its broader applications in studying bacterial communication and immune regulation.

Drug Delivery and Translational Research
University of Fribourg (CH), ETH Zurich (CH), Institute for Biomedical Engineering (CH), Biognosys (Switzerland) (CH), Phytronix (Canada) (CA), Hôpital de la Tour (CH)
Eidgenössische Technische Hochschule Zürich
Openalex Percentile: Top 10%
Bacterial Infections and Vaccines
2.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.